Novavax: COVID-19 Vaccine Granted Expanded Provisional Approval In New Zealand For Adolescents

Novavax, Inc. (NVAX) announced the New Zealand's Medsafe has granted expanded provisional approval for Nuvaxovid COVID-19 vaccine for active immunization to prevent COVID-19 in adolescents aged 12 through 17. New Zealand previously granted provisional approval for Nuvaxovid in adults aged 18 and older in February 2022 and for use as a booster in July 2022. The company noted that Nuvaxovid is New Zealand's only protein-based COVID-19 vaccine.

In the 12 through 17 year-old population, the Novavax COVID-19 vaccine has been granted authorization in India, the European Union, Australia, Japan, and Thailand.

For More Such Health News, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Nestle Purina PetCare Co. has recalled a limited amount of certain prescription wet dog food citing labeling error, the U.S. Food and Drug Administration said. The recall involves Purina Pro Plan Veterinary Diets EN Gastroenteric Low Fat or PPVD EN Low Fat wet dog food that comes in 13.4 oz cans. Exportadora Copramar is recalling 1260 cases of James Farm frozen raspberries citing potential to be contaminated with Hepatitis A, the U.S. Food and Drug Administration said. The recall involves James Farm branded frozen raspberries identified by UPC Code: 76069501010 and Lot Code - 22-165. American Honda Motor Co, Inc. has recalled about 2,900 units of 2022 model year Honda TRX90X All-Terrain Vehicles (ATVs) sold in the United States for possible crash and injury hazard, according to a statement issued by the U.S. Consumer Product Safety Commission or CPSC.
Follow RTT